US Stock Alert: ImmunityBio Plunged on October 19 Amid Pullback and Profit-Taking
Bitget异动解读2026/10/19 14:21ImmunityBio October 19th: Analysis of the Sharp Drop
Keywords: pullback from highs, profit-taking
As of October 19, 2026, ImmunityBio has fallen by a cumulative 15.76% over the past five days, though it is still up 330.56% year-to-date; the short-term pullback occurred after a significant rally earlier in the year. The market analysis on October 16 also indicated that profit-taking could intensify volatility.
(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nscale's IPO outlook boosted with Nvidia's support; Report: In talks with Anthropic on a $45 billion deal
If the agreement is implemented, the total scale of cooperation between the two parties will reach $90 billions. The relevant negotiations involve the second building of the Monarch data center campus, which provides 460MW of computing power and adopts NVIDIA’s latest generation Vera Rubin chips. In addition, Anthropic has also obtained the priority negotiation rights for the third building in the Monarch campus plan.

Nasdaq rose 1.11%, Amazon surged 4.98% and led the top trading volume stocks.

International oil prices fluctuated on October 19, New York oil price rose by 2.22%
Union Pacific defends Norfolk Southern deal benefits with detailed regulatory evidence